• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Private equity

Graphic of two hands shaking under a red and purple light
Manufacturing

PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT

Zentiva was Sanofi’s European generics business from 2008 until 2018, when Sanofi sold the manufacturer to Advent International for 1.9 billion euros.
Fraiser Kansteiner Sep 11, 2025 10:25am
Cambrex North Carolina

Permira eyes $4B sale of CDMO Cambrex: FT

Sep 9, 2025 10:36am
MA

As Bavarian Nordic reports sales boost, CEO pushes for takeover

Aug 22, 2025 11:30am
Bavarian Nordic

Bavarian Nordic's largest shareholder objects to $3B buyout bid

Jul 28, 2025 10:31am
MA

Bavarian Nordic confirms buyout talks

Jul 24, 2025 11:13am
increase

Bluebird investor reluctance pays off with better buyout offer

May 14, 2025 10:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings